6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern

Latest Press Releases

Time	Headline
25m ago	China Everbright Water : Minutes of the FY2025 Annual General Meeting
45m ago	Microsoft and Black Tech Street Launch Greenwood Cyber + AI Lab in Tulsa
1h ago	Liminatus Pharma Announces Nasdaq Delisting Notification
1h ago	Peyto Exploration & Development Corp. Announces Voting Results From Annual General Meeting of Shareholders
1h ago	Purecore Engages HEG & Associates for its 2026 Exploration Program at the Bankier Property

About

135.00TWD+9.00 +7.14%

Live at 01:46 GMT+00:00

Market Cap$262.80M

Volume166.6K

Beta0.37

RSI40.94

Gross Margin-104.63%

Health TechnologyPharmaceuticals: Major

Alar Pharmaceuticals Inc — investor relations, events, news, and company updates on 6ix.

Latest News

Alar Breaks Key Barriers in Ketamine Therapy with Positive Phase 1 Results for Long-Acting Injectable ALA-3000 for Treatment-Resistant Depression

Alar Announced Buprenorphine Injectable, ALA-1000, Demonstrated Long-Term Efficacy and Favorable Safety Profile in Canine Osteoarthritis Pain Management

Community Chat

Ask AI